Advanced search
Publication Cover
Nanomedicine Volume 6, 2011 - Issue 8
Submit an article Journal homepage
327
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Size Dependency of PLGA-Nanoparticle Uptake and Antifungal Activity Against Aspergillus Flavus

Nipur R Patel1 Louisiana State University Agricultural Center, Baton Rouge, LA, 70803, USA. [email protected]View further author information
,
Kenneth Damann1 Louisiana State University Agricultural Center, Baton Rouge, LA, 70803, USA. [email protected]View further author information
,
Claudia Leonardi1 Louisiana State University Agricultural Center, Baton Rouge, LA, 70803, USA. [email protected]View further author information
&
Cristina M Sabliov1 Louisiana State University Agricultural Center, Baton Rouge, LA, 70803, USA. [email protected]Correspondence[email protected]
View further author information
Pages 1381-1395 | Published online: 25 Oct 2011

Bibliography

  • Bala I , HariharanS, KumarM: PLGA nanoparticles in drug delivery: the state of the art.Crit. Rev. Ther. Drug Carrier Syst.21(5), 387–422 (2004).
  • Panyam J , LabhasetwarV: Biodegradable nanoparticles for drug and gene delivery to cells and tissue.Adv. Drug Deliv. Rev.55(3), 329–347 (2003).
  • Govender T , StolnikS, GarnettMC, IllumL, DavisS: PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.J. Control. Release57(2), 171–185 (1999).
  • Patravale VB , DateAA, KulkarniRM: Nanosuspensions: a promising drug delivery strategy.J. Pharm. Pharmacol.56(7), 827–840 (2004).
  • Nam YS , ParkJY, HanSH, ChangIS: Intracellular drug delivery using poly(D,L-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1.Biotechnol. Lett.24(24), 2093–2098 (2002).
  • Cheng J , TeplyBA, SherifiIet al.: Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.Biomaterials28(5), 869–876 (2007).
  • Song CX , LabhasetwarV, MurphyHet al.: Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery.J. Control. Release43(2–3), 197–212 (1997).
  • Kumari A , YadavSK, YadavSC: Biodegradable polymeric nanoparticles based drug delivery systems.Colloids Surf. B Biointerfaces75(1), 1–18 (2010).
  • Song X , ZhaoY, HouSet al.: Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency.Eur. J. Pharm. Biopharm.69(2), 445–453 (2008).
  • Brannon-Peppas L , BlanchetteJO: Nanoparticle and targeted systems for cancer therapy.Adv. Drug Deliv. Rev.56(11), 1649–1659 (2004).
  • Des Rieux A , FievezV, GarinotM, Schneider Y-J, Préat V: Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release116(1), 1–27 (2006).
  • Jeong YI , NaHS, SeoDHet al.: Ciprofloxacin-encapsulated poly(D,L-lactide-co-glycolide) nanoparticles and its antibacterial activity.Int. J. Pharm.352(1–2), 317–323 (2008).
  • Vila A , SánchezA, TobíoM, CalvoP, AlonsoMJ: Design of biodegradable particles for protein delivery.J. Control. Release78(1–3), 15–24 (2002).
  • Debeule K : Itraconazole: pharmacology, clinical experience and future development.Int. J. Antimicrob. Agents6(3), 175–181 (1996).
  • Willems L , Van Der Geest R, De Beule K: Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J. Clin. Pharm. Ther.26(3), 159–169 (2001).
  • Zhang L , PornpattananangkulD, HuCMJ, HuangCM: Development of nanoparticles for antimicrobial drug delivery.Curr. Med. Chem.17, 585–594 (2010).
  • Choi K-C , Bang J-Y, Kim P-I, Kim C, Song C-E: Amphotericin B-incorporated polymeric micelles composed of poly(D,L-lactide-co-glycolide)/dextran graft copolymer. Int. J. Pharm.355(1–2), 224–230 (2008).
  • Amaral AC , BoccaAL, RibeiroAMet al.: Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.J. Antimicrob. Chemother.63(3), 526–533 (2009).
  • Patel N , DamannK, LeonardiC, SabliovCM: Itraconazole loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activity.Nanomedicine5(7), 1037–1050 (2010).
  • Peng HS , LiuXJ, LvGXet al.: Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy.Int. J. Pharm.352(1–2), 29–35 (2008).
  • Elamanchili P , DiwanM, CaoM, SamuelJ: Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.Vaccine22(19), 2406–2412 (2004).
  • Gaumet M , VargasA, GurnyR, DelieF: Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.Eur. J. Pharm. Biopharm.69(1), 1–9 (2008).
  • Desai MP , LabhasetwarV, AmidonGL, LevyRJ: Gastrointestinal uptake of biodegradable microparticles: effect of particle size.Pharm. Res.13(12), 1838–1845 (1996).
  • Desai MP , LabhasetwarV, WalterE, LevyRJ, AmidonGL: The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.Pharm. Res.14, 1568–1573 (1997).
  • Florence AT , HussainN: Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.Adv. Drug Deliv. Rev.50(Suppl. 1), S69–S89 (2001).
  • Qaddoumi MG , UedaH, YangJ, DavdaJ, LabhasetwarV, LeeVH: The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.Pharm. Res.21, 641–648 (2004).
  • Rejman J , OberleV, ZuhornIS, HoekstraD: Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis.Biochem. J.377, 159–169 (2004).
  • Yin Win K , Feng S-S: Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials26(15), 2713–2722 (2005).
  • Prabha S , Zhou W-Z, Panyam J, Labhasetwar V: Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm.244(1–2), 105–115 (2002).
  • Zauner W , FarrowNA, HainesA: In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density.J. Control. Release71(1), 39–51 (2001).
  • Panyam J , SahooSK, PrabhaS, BargarT, LabhasetwarV: Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.Int. J. Pharm.262(1–2), 1–11 (2003).
  • Pietzonka P , Rothen-RutishauserB, LangguthP, Wunderli-AllenspachH, WalterE, MerkleH: Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to Caco-2 monolayers mimics particle uptake.Pharm. Res.19(5), 595–601 (2002).
  • Rajasekaran K , CaryJW, CottyPJ, ClevelandTE: Development of a GFP-expressing aspergillus flavus strain to study fungal invasion, colonization, and resistance in cottonseed.Mycopathologia165(2), 89–97 (2008).
  • Higuchi Y , NakahamaT, ShojiJ, AriokaM, KitamotoK: Visualization of the endocytic pathway in the filamentous fungus aspergillus oryzae using an EGFP-fused plasma membrane protein.Biochem. Biophys. Res. Commun.340(3), 784–791 (2006).
  • Higuchi Y , ShojiJY, AriokaM, KitamotoK: Endocytosis is crucial for cell polarity and apical membrane recycling in the filamentous fungus Aspergillus oryzae.Eukaryot. Cell8(1), 37–46 (2009).
  • Garraway MO : Fungal Nutrition and Physiology. Krieger Publishing, FL, USA (1992).
  • The Growing Fungus. Gow NA, Gad GM (Eds). Springer, NY, USA (1994).
  • Griffin DH : Fungal Physiology (2nd Edition). Wiley-Liss, NY, USA (1994).
  • Alzwei AO AK, Elgerbi AM, Candlish AAG: Production of extracellular enzymes and aflatoxins in solid substrate fermentation with aflatoxigenic Aspergillus spp. Mycotoxin Research20(2), 87–96 (2004).
  • Del Sorbo G , SchoonbeekHJ, De Waard MA: Fungal transporters involved in efflux of natural toxic compounds and fungicides. Fungal Genet. Biol.30(1), 1–15 (2000).
  • Jeon H-J , Jeong Y-I, Jang M-K, Park Y-H, Nah J-W: Effect of solvent on the preparation of surfactant-free poly(D,L-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int. J. Pharm.207(1–2), 99–108 (2000).
  • Zweers MLT , EngbersGHM, GrijpmaDW, FeijenJ: Release of anti-restenosis drugs from poly(ethylene oxide)-poly(D,L-lactic-co-glycolic acid) nanoparticles.J. Control. Release114(3), 317–324 (2006).
  • Leroux JC , AllemannE, DejaeghereF, DoelkerE, GurnyR: Biodegradable nanoparticles – from sustained release formulations to improved site specific drug delivery.J. Control. Release39(2–3), 339–350 (1996).
  • Polakovic M , GörnerT, GrefR, DellacherieE: Lidocaine loaded biodegradable nanospheres: II. Modelling of drug release.J. Control. Release60(2–3), 169–177 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.